about
Depletion of adult neurogenesis using the chemotherapy drug temozolomide in mice induces behavioural and biological changes relevant to depressionIcariside II induces cell cycle arrest and apoptosis in human glioblastoma cells through suppressing Akt activation and potentiating FOXO3a activity.Significance of Pretreatment Red Blood Cell Distribution Width in Patients with Newly Diagnosed Glioblastoma.Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.Parecoxib inhibits glioblastoma cell proliferation, migration and invasion by upregulating miRNA-29cThe Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.pH-Sensitive O6-Benzylguanosine Polymer Modified Magnetic Nanoparticles for Treatment of Glioblastomas.Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.Biomarkers and therapeutic advances in glioblastoma multiforme.The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction.Patient-derived glioblastoma stem cells respond differentially to targeted therapies.PIK3CB/p110β is a Selective Survival Factor for Glioblastoma.Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.Overall survival in patients with glioblastoma before and after bevacizumab approval.The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.Glioblastoma in hemihydranencephaly: preoperative and postoperative language ability of the right hemisphere.DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme.Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1.Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.Synergistic Effects of Arsenic Trioxide and Radiation: Triggering the Intrinsic Pathway of Apoptosis.Long non‑coding RNA ferritin heavy polypeptide 1 pseudogene 3 controls glioma cell proliferation and apoptosis via regulation of the microRNA‑224‑5p/tumor protein D52 axisThe p53 Pathway in GlioblastomaCandidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNAPhase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte countsTherapeutic Immunization against Glioblastoma
P2860
Q33635702-F472AE94-048E-4D16-96B5-91C7659363A8Q33733266-4035961E-8EF7-427C-ACE2-7F24D0A43376Q33894259-748B1612-41AD-4808-AFE3-66116779185CQ37349283-52271E3F-9BE3-42E7-8407-8F9AEAEE15C6Q37731274-B38FBCEC-9E4D-4DF9-AC39-17F24B21D94DQ38612761-4C6E7D9C-6794-48EC-9E1B-5B30E22BF101Q38694505-AF14C6DE-AD21-41C9-AE4B-9D6AC248B54BQ38726887-3CBB8D03-1E27-4202-8399-11D81281C1ACQ38752350-B11CDC58-D168-4B12-BDBD-3B6EDCC1F5FFQ40070524-6E0E77A4-2E8B-467F-9402-E8C9DDDB2CCEQ42056934-E8D0E07E-2ABB-4A54-B829-FD7F6B1ADAEBQ42222793-1A817128-C4F7-4025-8908-006E9C17B411Q42316508-702AA154-A5F2-411D-80FF-6EDEE8808D6FQ45069699-F6180128-17B7-42FA-B1D6-C651345787F6Q47720697-6FEAE182-E5B5-42FB-AD43-496701103CFAQ47809684-BB3BABA5-0A32-48BF-96C6-5CA88DDE15ADQ47868509-C81461FA-58E5-4DEB-B7DC-0DA4EE6D7D3FQ48768021-92A3D802-E11A-4917-954D-0EDE2F0465EFQ49956296-EDE70A10-D24A-4DCC-8B43-80A902514876Q50920629-82C6B887-D6F3-4DE0-B5F1-4AF7F2F4BF76Q51746207-3960620C-7F8B-419C-AB78-B28256BE49EFQ54970083-B309FB08-23E3-495B-8F0C-2003219DF80DQ54987791-4A0BC18A-F92F-40E8-B127-1530A48BB72DQ57157341-72F4D61C-F44E-46CF-9587-C98F557B2F0DQ57162865-80333194-3821-47FC-BE56-14C44783923DQ57821224-1F0BB75B-EE1B-455A-8F7C-2EA4CA45E9D3Q58692202-51684F84-381E-4F31-80B3-D7DF92D69CCDQ58700123-36246343-5206-4EDC-B6EA-2EFAF51152A5
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Nonsurgical treatment of recurrent glioblastoma
@ast
Nonsurgical treatment of recurrent glioblastoma
@en
Nonsurgical treatment of recurrent glioblastoma
@nl
type
label
Nonsurgical treatment of recurrent glioblastoma
@ast
Nonsurgical treatment of recurrent glioblastoma
@en
Nonsurgical treatment of recurrent glioblastoma
@nl
prefLabel
Nonsurgical treatment of recurrent glioblastoma
@ast
Nonsurgical treatment of recurrent glioblastoma
@en
Nonsurgical treatment of recurrent glioblastoma
@nl
P2860
P3181
P356
P1433
P1476
Nonsurgical treatment of recurrent glioblastoma
@en
P2093
P2860
P304
P3181
P356
10.3747/CO.22.2436
P407
P577
2015-08-01T00:00:00Z